000 01065 a2200301 4500
005 20250512110609.0
264 0 _c19751122
008 197511s 0 0 eng d
022 _a0032-5473
024 7 _a10.1136/pgmj.50.580.125
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeckett, A H
245 0 0 _aTrade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation.
_h[electronic resource]
260 _bPostgraduate medical journal
_cFeb 1974
300 _a125-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiological Availability
650 0 4 _aBiopharmaceutics
650 0 4 _aDrug Compounding
_xstandards
650 0 4 _aDrug Prescriptions
650 0 4 _aDrug Utilization
650 0 4 _aParticle Size
650 0 4 _aPatents as Topic
650 0 4 _aTerminology as Topic
650 0 4 _aTherapeutic Equivalency
773 0 _tPostgraduate medical journal
_gvol. 50
_gno. 580
_gp. 125-9
856 4 0 _uhttps://doi.org/10.1136/pgmj.50.580.125
_zAvailable from publisher's website
999 _c4470290
_d4470290